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Goals: Recent ﬁ  ndings suggest the prevalence of osteoporosis among men is under-recognized. 
The patient population of the Veterans Health Administration (VA) is predominantly male and 
many elderly veterans may be at risk of osteoporosis. Given the lack of data on male osteoporosis, 
we provide initial insight into diagnostic procedures for patients at one VA medical center. 
Procedures: A review and descriptive analysis of patients undergoing radiological evaluation 
for osteoporosis at one VA medical center. 
Results: We identiﬁ  ed 4,919 patients who had bone mineral density scans from 2001–2004. 
VA patients receiving bone mineral density scans were commonly white, male, over age 70 
and taking medications with potential bone-loss side effects. 
Conclusions: While further research is needed, preliminary evidence suggests that the VA 
screens the most vulnerable age groups in both genders. Heightened awareness among primary 
care providers of elderly male patients at risk of osteoporosis can lead to early intervention and 
improved management of this age-related condition.
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Introduction
Osteoporosis is a medical condition deﬁ  ned by low bone density and reduced bone 
strength that increases the risk of fractures. Largely associated with post-menopausal 
Caucasian women, recent ﬁ  ndings suggest the prevalence of osteoporosis among elderly 
men is under-recognized. The Surgeon General identiﬁ  es males as a population facing 
barriers to optimal bone health, stating that 13% of Caucasian men aged 50 and over 
will have an osteoporotic fracture of the wrist, spine, or hip (DHHS 2004). Research 
on male osteoporosis is limited with no national guidelines for prevention or treatment 
expressly for men (Binkley and Krueger 2002; Campion and Maricic 2003; Vonderacek 
and Hasen 2004). Adler has studied osteoporosis in veterans served in pulmonary 
clinics and using glucocorticoids (Adler and Hochberg 2003; Adler et al 2003), but 
we are unaware of any studies or internal directives addressing the Veterans Health 
Administration’s (VA) diagnostic procedures for the wider range of patients who may 
be at risk of osteoporosis. The purpose of our analysis is to describe patients who have 
received a radiological evaluation of osteoporosis (ie, those considered high risk) at 
one VA medical center (VAMC), providing insight into existing diagnosis procedures 
in a large healthcare system serving a predominantly male population.
Background
Veterans and male osteoporosis
The VA operates the largest integrated healthcare system in the country. There is ample 
evidence that VA patients are more medically needy than typical patients outside 
this system (Kazis et al 1998; Agha et al 2000; Yu et al 2003; DeSalvo et al 2005; Clinical Interventions in Aging 2007:2(2) 256
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Singh et al 2005), and many veterans may have multiple 
risk factors for osteoporosis. For instance, veterans have 
higher rates of smoking (VHA PHSHCG 2005) and home-
less veterans served by the VA have a myriad of nutritional 
deﬁ  ciencies and substance abuse problems (Gamache et al 
2000; O’Toole et al 2003; Nyamathi et al 2004). In addition, 
37% of all veterans in the United States are aged 65 and 
older (Cowper et al 2000). The presence of these risk factors 
suggests signiﬁ  cant clinical and ﬁ  nancial beneﬁ  ts from early 
detection of osteoporosis. Nonetheless, several researchers 
have determined that within the VA attention given to male 
osteoporosis is inadequate (Colon-Emeric et al 2000; Riley 
et al 2002; Adler and Hochberg 2003). 
Indicators for osteoporosis are aimed towards older 
women (NOF 2005), although there are differences in the 
presentation of osteoporosis by gender (Kamel 2004). Men 
have approximately 10% greater peak bone mass, are typi-
cally older by the onset of osteoporosis, and are less likely 
to have an associated fracture than women (Kamel 2004). 
When older men do have a hip fracture, they are at greater risk 
for institutionalization and mortality compared with women 
(Center et al 2000; Stevens and Olson 2000; Davidson et al 
2001; Fransen al 2002; Bass et al 2007). Due to advances 
in life expectancy, the number of individuals suffering from 
osteoporosis and related fractures will likely increase, and so 
will the economic burden. Lifetime costs for treating a hip 
fracture from one community-based study were estimated at 
US$81,300 (Braithwaite et al 2003). 
Risk factors for males are known and many apply to 
both genders (see Table 1). Diseases and medical condi-
tions which may cause osteoporosis include endocrine 
(such as thyroid disease), gastrointestinal (malabsorption 
issues with Vitamin D and calcium), chronic renal failure, 
malignancy, systemic mastocytosis, and idiopathic hyper-
calciuria (Compston 2001; NOF 2005). Glucocorticoids and 
other medications such as anticonvulsants, methotrexate, 
excessive thyroid hormone, cyclosporine A, antiandrogens, 
heparin, and cholestyramine can result in decreased bone 
density (Compston 2001; NOF 2005; Saad 2005; Shahinian 
et al 2005; Trant and Holbert 2006) .
Bone density scans
Several types of machines can measure bone density: 
only those used at the VAMC analyzed are included here. 
Dual-energy X-ray absorptiometry (DXA) scans are the 
standard for bone mineral density measurement and are 
used primarily for prefracture diagnosis of osteoporosis 
(ACOG 2004). With the use of X-rays, a two-dimensional 
image is generated, permitting the caluculation of bone 
mineral density (Wahner and Fogelman 1994). A central 
DXA is used for sites on the axial skeleton (eg, spine, 
femoral neck, hip) whereas a peripheral DXA is for the 
appendicular skeleton (eg, wrist, heel). DXAs expose 
patients to low levels of radiation and administration is 
typically uncomplicated, but there are some disadvan-
tages. Classifications are site-dependent: a patient may 
have a healthy spine measurement, but an osteoporotic 
hip. DXA machines have no universal calibration system 
so results may differ depending on the actual machine 
used. Machines cannot identify an unsatisfactory scan 
acquisition due to operator error, insufficient scan speed 
or patient movement. A quantitative computed tomogra-
phy (CT) may also be used to measure bone density in 
the spine using a conventional tomgraphy unit (Trand 
and Holbert 2006). Unlike a DXA machine which is used 
only for bone mineral density measurement, clinics that 
have CT units can use these machines for diagnosing 
multiple conditions. However, CT results do not always 
correspond well with a DXA and patients are exposed to 
higher levels of raditaion. Definitive data pertaining to 
the effectiveness of any screening and subsequent treat-
ment for osteoporosis is lacking (Kern et al 2005; Raisz 
2005), despite the widespread use of scans. The cost to 
the VAMC for administering each DXA scan in 2004 was 
US$189.34; CT scans cost US$130.16 (VHA 2005).
Table 1 General risk factors for osteoporosis in men
1.  Personal history of fracture after age 50 
2.  History of fracture in a 1st degree relative 
3.  Current low bone mass 
4.  Being thin and having a small frame, or both 
5. Advanced  age 
6.  A family history of osteoporosis 
7.  Low lifetime calcium intake 
8.  Vitamin D deﬁ  ciency 
9.   Use of certain medications (corticosteroids, chemotherapy, anticon-
vulsants and others) 
10.  Presence of certain chronic medical conditions 
11.  Low testosterone levels in men 
12.  An inactive lifestyle 
13.  Current cigarette smoking 
14.  Excessive use of alcohol 
15.   Being Caucasian or Asian, although African Americans and Hispanic 
Americans are at signiﬁ  cant risk as well 
Adapted with permission as excerpt from http://www.nof.org/osteoporosis/
diseasefacts.htm,
The National Osteoporosis Foundation, Washington DC 2007. All rights reserved.Clinical Interventions in Aging 2007:2(2) 257
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Data source and methods
The sample for this study was drawn from one of the nation’s 
busiest VAMCs, located in the state with the largest num-
ber of elderly veterans (Cowper et al 2000). The VAMC 
encompasses one hospital, three regional outpatient clinics, 
and ﬁ  ve smaller community-based outpatient clinics. Of 
the nine facilities, only the hospital has a DXA machine (a 
Lunar DPX-1Q; Lunar, Madison, Wisconsin, USA). The 
outpatient clinics use an axial CT bone density scan or refer 
patients to the hospital. The data were assembled from local 
the Veterans Health Information Systems and Technology 
Architecture (VistA), which is an integrated system of 
software applications assisting with patient healthcare and 
management at VA facilities (VIReC 2004). Each VAMC 
maintains its own VistA which contains administrative and 
some clinical information such as patients’ medical and 
healthcare utilization histories, demographics, practitioner 
information, diagnoses, and procedures (VIReC 2004). 
All patients treated at VA medical centers are included in 
the ﬁ  les which are updated during ofﬁ  ce visits or as part of 
administrative processes.
We performed a search of VistA by extracting all ﬁ  les 
from the financial year (October 1st–September 30th) 
2000–2004 for patients receiving any of three procedures 
deﬁ  ned by common procedure terminology (CPT) codes 
76070 (axial CT bone density scan), 76075 (axial skeleton 
study DXA) or 76076 (peripheral study DXA). Screening 
males with a DXA machine began late in 2000; therefore, our 
period of measurement is 2001–2004. Descriptive statistics 
of scan recipients and time trends were examined by select 
demographics, primary and secondary diagnoses, and the 
utilization of potential bone-loss drugs. Descriptive statistics 
include counts, percentages, and chi-square statistics testing 
whether the composition of the scan population remained 
constant over time. Analyses were conducted with SAS 9.1 
(SAS Institute Inc., Cary, NC, USA).
Results
Demographics
We identiﬁ  ed 4,919 patients who had 6,743 scans. The total 
number of all scans rose by approximately 5% annually 
from 2001 to 2003, with a 14% jump in 2004. Peripheral 
DXA scans remained a very small proportion of total scans, 
as seen in Table 2. Comparing the two axial skeleton pro-
cedures, the trend from 2001–2004 shows a signiﬁ  cant 
increase (p < 0.001) of CT scans for both males (Figure 1) 
and females. Fifty-ﬁ  ve percent (3,730) of the scans over the 
four year time period were given to men. Whereas the total 
number of scans given to women decreased, the share of 
scans performed for male patients increased from 37% in 
2001 to 66% in 2004, a statistically signiﬁ  cant change in the 
gender composition (p < 0.001).
The four year annual average conﬁ  rmed that men in the 
age group 70–79 received the most scans (Table 3). Over half 
Table 2 Annual scan procedures (CPT codes) by gender
  Number performed (percent)*
 FY2001  FY2002  FY2003  FY2004
Male
CT Bone Density, Axial (76070)  47  (8)  83  (9)  187  (19)  326  (26)
DXA, Axial (76075)  493  (86)  806  (89)  760  (77)  912  (72)
DXA, Appendicular (peripheral) (76076)  32  (6)  ◊   (2)  34  (3)  32  (3)
Total 572    907    981    1,270 
Change from previous year      59%    8%    29% 
              
Female              
CT Bone Density, Axial (76070)  47  (5)  52   (7)  70  (10)  130  (20)
DXA, Axial (76075)  896  (93)  641  (91)  606  (86)  502  (78)
DXA, Appendicular (peripheral)  ◊   ◊   ◊  ◊
(76076)   (2)    (2)    (4)    (2)
Total 960    708    701    644 
Change from previous year      –26%    –1%    –8% 
              
Total scans (both genders) 1,532    1,615    1,682    1,914 
Percent male  37%    56%    58%    66% 
Note: *Percentages may not equal 100 due to rounding; n = 6,743; ◊ The exact number (and percent) less than 30 not reported; sourced from VistA with calculations by 
the authors.
Abbreviations: CPT, common procedure terminology; CT, computed tomography; DXA, dual-energy X-ray absorptiometry, FY, ﬁ  nancial year. Clinical Interventions in Aging 2007:2(2) 258
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(54%) of male scans were given to those between the ages 
of 60 and 79. In contrast, the largest group of females was in 
the 50–59 range, accounting for 36% of scans over the four 
year span. For women, this age group constantly composed 
the largest proportion of scans. For men the most consistent 
and signiﬁ  cant growth in scans was for the aged 80 and over 
group (Figure 2). Age distribution changed signiﬁ  cantly over 
time for both genders (p < 0.001). 
Since there was little change in the sample by race, we 
report the annual average from 2001–2004. The majority 
(74%) of male scan recipients were identiﬁ  ed as non-Hispanic 
whites. An average of 18% of male scan recipients did not 
have a speciﬁ  ed race recorded, as is the case for VA records 
in general. Five percent were black. Numbers in the remain-
ing categories (American Indian/Alaskan Native, Asian, and 
Hispanic) were too small to report. The race distribution 
of females was similar, with a larger percentage (24%) of 
unknown race. 
Common diagnoses
We report the four years combined of diagnoses information 
since there was no change over time in the types of diagnoses 
for scan recipients during their inpatient stay or clinic visit. 
There was little variation by gender in the primary admitting 
diagnoses for inpatients who received bone density scans. 
Most inpatients were seen for either multiple or orthopedic 
rehabilitation, or aftercare from surgery. Older patients had 
a higher frequency of heart disease. Hyperlipidemia was 
the common secondary diagnosis for both genders in most 
age groups (hypertension is the most frequent secondary 
diagnosis of all VA patients, regardless of primary admitting 
diagnosis). Primary diagnoses in the outpatient setting were 
exclusively for counseling.
While not among the most common diagnoses, a sizable 
portion of male patients screened had spinal cord injury. In 
2003, these patients composed 11% of all those receiving 
bone density scans. Since every spinal cord injury patient 
had a positive diagnosis, it became routine practice became 
to treat most spinal cord injury patients for osteoporosis, 
reducing—and eventually eliminating—the scans ordered 
by the Spinal Cord Injury Clinic service.
Medication use
Table 4 shows the percentage of scan recipients who either had 
a prescription for or received intravenously any of the medica-
tions listed above as damaging to the skeleton (glucocorticoids, 
excessive thyroid hormones, anticonvulsants, methotrexate, 
cyclosporine A, anti-androgens, heparin, and cholestyramine). 
Figure 1 Bone mineral density scans for males, 2001–2004.
Note: n = 3,730; sourced from VistA with calculations by the authors. 
Abbreviations: CT, computed tomography; DXA, dual-energy X-ray absorptiometry, FY, ﬁ  nancial year. 
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Data on dosage or duration was not available for analysis. Ste-
roids were the most common drug for both genders. One quarter 
of male scan patients and 20% of females had a prescription for 
Gabapentin. Levothyoxine had a much larger share of female 
patients. From 2001–2004, the proportion of males with these 
prescriptions converged to the level observed in females, ap-
proximately 55%, which had remained relatively stable with no 
statistically signiﬁ  cant change (p = 0.18; data not shown). 
Discussion 
By 2004, the large VAMC examined here had concentrated the 
delivery of bone density scans in the hospital setting, though 
approximately one quarter was performed at outpatient clin-
ics. While the hospital utilized a DXA machine, the outpatient 
clinics used CT scans. Almost all the growth in CT scans 
was accounted for by one outpatient clinic. Why scans were 
increasing at that site could not be determined. The decrease 
in the number of axial DXA scans from 2002 to 2003 may 
have been inﬂ  uenced by the policy of the Spinal Cord Injury 
Clinic to no longer send its patients for DXA scans. The low 
frequency of peripheral DXAs reﬂ  ects appropriate standard of 
care since these scans are not used for diagnosis. 
The composition of the scan population did not remain 
constant over the years examined. By 2004, the typical patient 
receiving a bone mineral density scan in this VAMC was 
male. There is no clear explanation for the increase in male 
scans. New primary providers (who order scans) may have 
been hired, provider behavior may have changed, or access 
may have been easier for male patients beginning in 2000 
when the DXA machine was moved from the Women’s 
Clinic to Radiology due to space constraints. Male scan 
patients were signiﬁ  cantly older by 2004 than in 2001, and 
older than women receiving scans. Conversely, the average 
age for women decreased over the four year span, though 
two-thirds of women scanned still were post-menopausal. 
This supports the view that osteoporosis manifests later in 
men than women and suggests that the VA screens the most 
vulnerable age groups in both genders. The decrease in scans 
ordered from the Spinal Cord Injury Clinic whose patients 
tend to be younger may also have contributed to the age 
shift. Generalizations from analysis of the race variable are 
problematic due to the large proportion of missing values, 
but at least 74% of male and 67% of female scan recipients 
were Caucasian. These Caucasian majorities may reﬂ  ect 
the VA patient population served at this particular VAMC 
(predominantly white), or show awareness by clinicians 
regarding the heightened risk for this racial group.
Primary and secondary diagnoses of scan recipients did 
not appear different from what is expected in the general 
elderly patient population. Rehabilitation, aftercare from 
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
FY2001 FY2002 FY2003 FY2004
P
e
r
c
e
n
t
Under 40
40–49
60–69
70–79
80+
50–59
Figure 2 Trends for male scan recipients by age, 2001–2004.
Note: sourced from VistA with calculations from the authors.
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Table 3 Age distribution (percentages)* by gender of scan recipients by ﬁ  rst and last year of study, including four year annual average
Males FY2001  FY2002  FY2003  FY2004  Average
under 40  3.3  2.8  2.1  2.5  2.7
40–49  8.9  9.1  7.85 7.4 8.3
50–59 22.9  21.1  21.4  19.5  21.2
60–69 25.7  23.5  24.9  21.7  23.9
70–79 28.9  29.2  31.0  31.2  30.1
80 and over  10.3  14.3  12.7  17.7  13.8
Sample size  572  907  981  1,270 
Females       
under 40  2.0  1.55  2  2.8  2.1
40–49 13.2  19.9  17.4  17.7  17.1
50–59 33.2  33.9  35.5  42.4  36.3
60–69 25.7  21.9  21.7  19.7  22.3
70–79  17.7  15.7  14.3 8.9 14.1
80 and over  8.1  7.1  9.1  8.5  8.2
Sample size  960  708  701  644 
Note: *Percentages may not equal 100 due to rounding; sourced from VistA with calculations by the authors. 
Abbreviations: FY, ﬁ  nancial year.
Table 4 Scan patients (%)* receiving drugs with potential bone-
loss side effects 2001–2004
Medication Males  Females
Steroids 36%  26%
Anticonvulsants 30%  21%
   Gabapentin (enzyme noninducing) 26%  19%
   Dilantin (enzyme inducing) 8%  4%
Thyroid 10%  22%
Methotrexate 7%  3%
Heparin   5%  2%
   Heparin 3%  1%
   Low molecular weight Heparin 3%  1%
Cyclosporine A  2%  0%
Antiandrogen 2%  0%
Cholestyramine 0%  0%
Note: *Possible multiple medications per patient: percentages do not total 100; 
n = 4,919; sourced from VistA with calculations from the authors.
surgery, counseling, hypertension, and hyperlipidemia were 
common. High-risk conditions such as thyroid disease or 
metastatic prostate cancer were unevenly distributed. 
VA clinicians are monitoring patients using drugs with 
potential bone-loss side effects. The most common medications 
taken by scan patients were steroids. While short-term steroid use 
causes little concern, steroid-induced osteoporosis can develop in 
patients whose usage extends beyond 3 months (Van Staa et al 
2000). The second largest medication group was anticonvulsants. 
Some anticonvulsant use is accounted for by the uniqueness 
of this scan population: approximately half of the spinal cord 
injury patients take gabapentin. There is disagreement as to the 
association of this newer anticonvulsant with osteoporosis (Pack 
and Morrell 2001; Asconape 2002), but we included gabapentin 
as it is in the class of drugs historically associated with potential 
bone loss. Levothyoxine had a larger share of female patients, 
explained by the higher frequency of thyroid problems in women. 
As with steroids, data on duration and dosage of thyroid medica-
tion to determine if use were “excessive” would have been useful. 
Over the four year time span, the percent of men receiving scans 
who were taking the aforementioned drugs fell and by 2004 mir-
rored that of women. The reasons for this convergence may be 
coincidental or due to systematic change in physician practice (ie, 
fewer male patients were prescribed these medications, or fewer 
male patients given these medications were being screened). We 
were unable to determine which was more likely. It is important 
to note that these pharmaceutical records may be incomplete for 
patients who also seek care outside the VA.
There are several limitations of our study in addition to 
those explained above. This research describes patients at 
one VAMC, so results may not necessarily be generalized to 
national patient populations. In addition, some patients may 
have been receiving care outside the VA, so some patient-
level data may be absent. Complete information on lifestyle 
behaviors, such as smoking, was lacking. We did not have 
information on which clinics or providers ordered the scans, 
nor the test results. Finally, our results are suspect to the general 
shortcomings of using a chieﬂ  y administrative database. 
Conclusions
The large VAMC examined here averaged 1,900 bone mineral 
density scans annually by 2004. In general, VA patients receiv-
ing bone mineral density scans are white, male, over age 70, 
and taking medications with potential bone-loss side effects. Clinical Interventions in Aging 2007:2(2) 261
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This is a different group from the female patient population 
usually screened for osteoporosis outside the VA. Our ﬁ  ndings 
suggest that VA diagnostic procedures target high-risk patients 
in their population of primarily elderly males, indicating ap-
propriate resource utilization. The larger question is how much 
of the high-risk patient population is screened. 
Osteoporosis is a serious health issue that is not con-
ﬁ  ned to elderly women. Fortunately osteoporosis is largely 
preventable and treatable. Primary care providers may help 
elderly male patients better manage osteoporosis through 
early detection. Performing bone density scans in men at 
risk for osteoporosis can facilitate timely treatment and may 
reduce the incidence of debilitating, costly fractures. 
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